Scleroderma is a rare disease in which a person's immune system begins to destroy normal, healthy tissues. (This is called an autoimmune disease.) As a result, connective tissue of the skin, lungs, ...
Among the total systemic sclerosis cohort, 14% of individuals were categorized as frail and 53% as prefrail, with frailty status linked to an increased risk for mortality.
Systemic scleroderma involves more widespread areas of tissue change but may begin as patches of hardened or tightened skin, especially in cutaneous systemic sclerosis, a subtype of systemic ...
Scleroderma is classified as a rare ... rheumatologist at a nearby university medical department who diagnoses systemic sclerosis. She and her husband are frightened, especially when she is ...
Acute and chronic renal diseases remain common complications of systemic sclerosis. Although treatment for acute scleroderma renal crisis may arrest the rapid progression of renal disease ...
Systemic sclerosis, also termed scleroderma, is a multisystem connective tissue disease involving autoimmunity, inflammation, fibrosis and vasculopathy. The clinical presentation of systemic ...
Low doses of glucocorticoids added to immunosuppression yield no significant benefit for skin fibrosis in early diffuse ...
Systemic sclerosis (SSc) is a rare connective tissue ... Of note, SSc has traditionally sometimes also been called ...
A NEW Swedish study has found that menopausal hormone therapy (MHT) may be associated with an increased risk of developing ...
Scleroderma is a chronic autoimmune disease of women. Over time, people living with scleroderma develop progressive and ...
Frailty among patients with systemic sclerosis significantly increases ... determine whether measuring the frailty of patients with scleroderma, rather than assessing the involvement of various ...
in sera from patients with systemic sclerosis (scleroderma). The authors performed a series of experiments that confirmed that these antibodies recognized and activated native PDGFR on fibroblasts.